Current diagnosis and treatment of migraine;Aktuelle diagnostik und therapie der migräne

Schmerz

Volumn 22, Issue SUPPL. 1, 2008, Pages 51-60

  Diener, H C ^a   Katsarava, Z ^a   Limmroth, V ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b KRANKENHAUS MERHEIM   (Germany)

Author keywords

Chronic migraine; Epidemiology; Headaches; Migraine; Migraine prevention

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; AMITRIPTYLINE; BISOPROLOL; BISOPROLOL FUMARATE; BOTULINUM TOXIN; CALCIUM ANTAGONIST; CYCLANDELATE; DIHYDROERGOTAMINE; DOMPERIDONE; ELETRIPTAN; ERGOTAMINE DERIVATIVE; FLUNARIZINE; FROVATRIPTAN; MAGNESIUM; METOCLOPRAMIDE; METOPROLOL; METOPROLOL TARTRATE; NAPROXEN; NARATRIPTAN; PARACETAMOL; PLACEBO; PROPRANOLOL; RIBOFLAVIN; RIZATRIPTAN; SALICYLIC ACID DERIVATIVE; SUMATRIPTAN; TOPIRAMATE; TRIPTAN DERIVATIVE; VALPROIC ACID; ZOLMITRIPTAN;

COMORBIDITY; HEADACHE; HUMAN; MEDICAL PRACTICE; MIGRAINE; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; SYMPTOM;

ACUPUNCTURE THERAPY; ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANALGESICS; BEHAVIOR THERAPY; CALCIUM CHANNEL BLOCKERS; CHILD; CLINICAL TRIALS AS TOPIC; COMORBIDITY; DEPRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; MIGRAINE DISORDERS; NEUROTRANSMITTER AGENTS; PREVALENCE; SEROTONIN AGONISTS; SEX FACTORS; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 40149091074     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-007-0619-3     Document Type: Review

References (72)

1. Ahonen K, Hamalainen ML, Eerola M et al. (2006) A randomized trial of rizatriptan in migraine attacks in children. Neurology 67: 1135-1140
2. Aurora SK, Gawel M, Brandes JL et al. (2007) Botulinum toxin type A prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Headache 47: 486-499
3. Ayata C, Jin H, Kudo C et al. (2006) Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 59: 652-661
4. Bigal ME, Lipton RB (2006) Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 67: 252-257
5. Bousser M-G (2006) Patent foramen ovale and migraine: evidence for a link? Headache Curr 3: 44-51
6. Brandes JL, Kudrow D, Stark SR et al. (2007) Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA 297: 1443-1454
7. Bussone G, Diener H, Pfeil J et al. (2005) Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract 59: 961-968
8. Creutzig A, Alexander K (1985) Ergotismus. Dtsch Med Wochenschr 110: 1420-1422
9. Dahloef CG (2006) Infrequent or non-response to oral sumatriptan does not predict response to other triptans - review of four trials. Cephalalgia 26: 98-106
10. Dichgans J, Diener HC, Gerber WD et al. (1984) Analgetika-induzierter Dauerkopfschmerz. Dtsch Med Wochenschr 109: 369-373
11. Diener HC (2005) Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg. Curr Med Res Opin 21: 1603-1610
12. Diener HC, for the ASASUMAMIG Study Group (1999) Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. Cephalalgia 19: 581-588
13. Diener HC, Limmroth V (2004) Medication-overuse headache: a worldwide problem. Lancet Neurol 3: 475-483
14. Diener H, Limmroth V, Fritsche G et al. (2005) Therapie der Migräneattacke und Migräneprophylaxe. Leitlinie der Deutschen Gesellschaft für Neurologie und der Deutschen Migräne- und Kopfschmerzgesellschaft. In: Diener H, für die Kommission Leitlinien der DGN (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie, 3. Aufl. Thieme, Stuttgart New York
15. Diener H, Pfaffenrath V, Pageler L et al. (2005) The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multi-centre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25: 776-778
16. Diener HC, Kronfeld K, Boewing G et al. (2006) Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol 5: 310-316
17. Diener H, Bussone G, Van Oene J et al. (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia in press
18. Diener HC, Kurth T, Dodick D (2007) Patent foramen ovale and migraine. Curr Pain Headache Rep 11: 236-240
19. Diener HC, Kurth T, Dodick D (2007) Patent foramen ovale, stroke, and cardiovascular disease in migraine. Curr Opin Neurol 20: 310-319
20. Dodick D, Lipton R, Martin V et al. (2004) Triptan Cardiovascular Safety Expert Panel. Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Headache 44: 414-425
21. Dodick DW, Martin VT, Smith T et al. (2004) Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache [Suppl 1] 44: S20-30
22. Dodick DW, Mauskop A, Elkind AH et al. (2005) Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache 45: 315-324
23. Dowson AJ, Wilmshurst P, Muir KW et al. (2006) A prospective, multicenter, randomized, double blind, placebo-controlled trial to evaluate the efficacy of patent foramen ovale closure with the STARFlex septal repair implant to prevent refractory migraine headaches: the MIST trial. Neurology 67: 185
24. Eulenburg A (1887) Zur Aetiologie und Therapie der Migräne. Wien Med Presse 28: 3-8
25. Fasmer OB (2001) The prevalence of migraine in patients with bipolar and unipolar affective disorders. Cephalalgia 21: 894-899
26. 1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358: 1668-1675
27. Fiore M, Shields KE, Santanello N et al. (2005) Exposure to rizatriptan during pregnancy: post-marketing experience up to 30 June 2004. Cephalalgia 25: 685-688
28. Fox AW, Chambers CD, Anderson PO et al. (2002) Evidence-based assessment of pregnancy outcome after sumatriptan exposure. Headache 42: 8-15
29. Füeßel H (1987) Chronischer Ergotismus. Selecta 33: 20063
30. Goldstein J, Silberstein SD, Saper JR et al. (2006) Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study. Headache 46: 444-453
31. Goldstein J, Tiseo PT, Albert KS ert al. (2006) Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan. Headache 46: 1142-1150
32. Hadjikhani N, Sanchez del Rio M, Wu O et al. (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 98: 4687-4692
33. Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia [Suppl 7] 8: 1-93
34. Horton BT, Peters GA (1963) Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 3: 214-226
35. Humphrey PPA, Feniuk W, Perren M et al. (1989) Sumatriptan succinate. Drugs Future 14: 35-39
36. Källen B, Lygner PE (2001) Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache 41: 351-356
37. Kavuk I YA, Cetindere U, Agelink MW et al. (2003) Epidemiology of chronic daily headache. Eur J Med Res 8: 236-240
38. Kirchmann M, Thomsen LL, Olesen J (2006) Basilar-type migraine: clinical, epidemiologic, and genetic features. Neurology 66: 880-886
39. Kurth T, Slomke MA, Kase CS et al. (2005) Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 64: 1020-1026
40. Kurth T, Gaziano JM, Cook NR et al. (2006) Migraine and risk of cardiovascular disease in women. JAMA 296: 283-291
41. Kurth T, Holtmann G, Neufang-Huber J et al. (2006) Prevalence of unexplained upper abdominal symptoms in patients with migraine. Cephalalgia 26: 506-510
42. Kurth T, Gaziano JM, Cook NR et al. (2007) Migraine and risk of cardiovascular disease in men. Arch Intern Med 167: 795-801
43. Lanteri-Minet M, Radat F, Chautard MH et al. (2005) Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management. Pain 118: 319-326
44. Leinisch E, Evers S, Kaempfe N et al. (2005) Evaluation of the efficacy of intravenous acetaminophen in the treatment of acute migraine attacks: a double-blind, placebo-controlled parallel group multicenter study. Pain 117: 396-400
45. Lewis D, Ashwal S, Hershey A et al. (2004) Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 63: 2215-2224
46. Limmroth V, Katsarava Z, Fritsche G et al. (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59: 1011-1014
47. Linde K, Streng A, Jurgens S et al. (2005) Acupuncture for patients with migraine: a randomized controlled trial. JAMA 293: 2118-2125
48. MacGregor EA, Frith A, Ellis J et al. (2006) Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 67: 2159-2163
49. Mannix LK, Savani N, Landy S et al. (2007) Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies. Headache 47: 1037-1049
50. Neuhauser HK, Radtke A, Brevern M von et al. (2006) Migrainous vertigo: prevalence and impact on quality of life. Neurology 67: 1028-1033
51. O'Quinn S, Ephross SA, Williams V et al. (1999) Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study. Arch Gynecol Obstet 263: 7-12
52. Oedegaard KJ, Neckelmann D, Mykletun A et al. (2006) Migraine with and without aura: association with depression and anxiety disorder in a population-based study. The HUNT Study. Cephalalgia 26: 1-6
53. Olesen C, Steffensen FH, Sorensen HT et al. (2000) Pregnancy outcome following prescription for sumatriptan. Headache 40: 20-24
54. Olesen J, Bousser M-G, Diener H et al. for the International Headache Society (2004) The international classification of headache disorders, 2nd edn. Cephalalgia [Suppl 1] 24: 1-160
55. Olesen J, Diener H, Husstedt IW et al. for the BIBN 4096 BS Clinical Proof of Concept Study Group (2004) Calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS is effective in the treatment of migraine attacks. N Engl J Med 350: 1104-1110
56. Paemeleire K, Bahra A, Evers S et al. (2006) Medication-overuse headache in patients with cluster headache. Neurology 67: 109-113
57. Peters GA, Horton BT (1951) Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc Staff Meet Mayo Clin 26: 153-161
58. Radat F, Swendsen J (2005) Psychiatric comorbidity in migraine: a review. Cephalalgia 25: 165-178
59. Rothner AD, Wasiewski W, Winner P et al. (2006) Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents. Headache 46: 101-109
60. Sanchez del Rio M, Bakker D, Wu O et al. (1999) Perfusion weighted imaging during migraine: spontaneous visual aura and headache. Cephalalgia 19: 701-707
61. Scher AI, Bigal ME, Lipton RB (2005) Comorbidity of migraine. Curr Opin Neurol 18: 305-310
62. Scher A, Terwindt G, Picavet H et al. (2005) Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 64: 614-620
63. Schulman E, Dermott K (2003) Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs. Headache 43: 729-733
64. Schwartz BS, Stewart WF, Simon D et al. (1998) Epidemiology of tension-type headache. JAMA 279: 381-383
65. Shuhaiber S, Pastuszak A, Schick B et al. (1998) Pregnancy outcome following first trimester exposure to sumatriptan. Neurology 51: 581-583
66. Silberstein SD, Lipton RB (1993) Epidemiology of migraine. Neuroepidemiology 12: 179-194
67. Silberstein SD, Lipton RB, Dodick DW et al. (2007) Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 47: 170-180
68. Silvestrini M, Bartolini M, Coccia M et al. (2003) Topiramate in the treatment of chronic migraine. Cephalalgia 23: 820-824
69. Smith TR, Sunshine A, Stark SR et al. (2005) Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache 45: 983-991
70. Tfelt-Hansen P, Iversen HK (1991) Subcutaneous sumatriptan in acute migraine. JAMA 266: 2703-2704
71. Wilmshurst PT, Pearson MJ, Nightingale S et al. (2004) Inheritance of persistent foramen ovale and atrial septal defects and the relationship to familial migraine with aura. Heart 90: 1245-1247
72. Zschiedrich M, Heidrich H, Dienes HP (1985) Ergotismus: Epidemiologie, Pathogenese, Histomorphologie, Diagnostik und Therapie. Med Klin 80: 721-727